BACKGROUND: Little is known about resource utilization (number of days in the hospital or medical care) between diagnosis and @entity204 in @entity1 with @entity788 . METHODS: Using Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data, we identified 25,476 @entity1 with @entity788 (1992-2005). Hospital and medical care days per @entity1 -month from the time of diagnosis were described, stratified by stage, treatment, and survival duration. RESULTS: Hospital/medical care days vary by length of survival and treatment strategy in @entity1 with @entity788 . For all stages, @entity1 were in the hospital a mean of 6.4 days and received medical care a total of 9.0 days in the first month after diagnosis, decreasing to 1.7 and 3.7 days per month, respectively, by the end of the first year. Hospital/medical care days per month of life were higher in @entity1 with shorter survival but increased sharply at the end of life in all @entity1 , regardless of duration of survival. In @entity1 with locoregional disease, resection was associated with a higher number of hospital/medical care days during the first 4 months after diagnosis, but fewer at the end of the first year. For distant disease, hospital days were similar but days in medical care were higher for @entity1 receiving chemotherapy, increasing especially at the end of life. CONCLUSIONS: This study is the first to quantify hospital/medical care days in @entity1 with @entity788 by stage, treatment, and survival. This information will provide realistic expectations and allow for treatment decisions based on @entity1 preferences.

Hospital and medical care days in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'person'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatic cancer'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity788 :: (MESH:D010190,Disease) :: ['pancreatic cancer']
